SCHEMBL13293126

SCHEMBL13293126

C=C(C)[C@@H]1CC[C@]2(CC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC/C(=N/O)C(C)(CO)[C@@H]5CC[C@]43C)[C@@H]12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.58
▸ PTPN1 P18031 3/20 0.58
▸ NT5E P21589 2/20 0.58
▸ TOP2A P11388 2/20 0.58
▸ USP2 O75604 2/20 0.58
▸ HIF1A Q16665 2/20 0.58
▸ RELA Q04206 1/20 0.58
▸ EGLN2 Q96KS0 1/20 0.56
▸ EGLN1 Q9GZT9 1/20 0.56
▸ EGLN3 Q9H6Z9 1/20 0.56
▸ P4HTM Q9NXG6 1/20 0.56
▸ PTGES O14684 1/20 0.52
▸ GPBAR1 Q8TDU6 5/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ CES2 O00748 2/20 0.49
▸ CES1 P23141 2/20 0.49
▸ F3 P13726 1/20 0.49
▸ CA9 Q16790 3/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13293154 0.95 LMNA (0.65) LMNAPTPN1NT5ETOP2AUSP2
SCHEMBL13293199 0.89 SLC10A1 (0.58) LMNAPTPN1NT5ETOP2AUSP2
SCHEMBL13164848 0.89 TOP2A (0.59) LMNAPTPN1NT5ETOP2AUSP2
SCHEMBL13293241 0.88 LMNA (0.55) LMNAPTPN1NT5ETOP2AUSP2
SCHEMBL13304151 0.87 LMNA (0.54) LMNAPTPN1NT5ETOP2AUSP2
SCHEMBL13293265 0.87 LMNA (0.54) LMNAPTPN1NT5ETOP2AUSP2
SCHEMBL16704981 0.87 GPBAR1 (0.69) LMNAPTPN1NT5EUSP2HIF1A
SCHEMBL13293178 0.87 GPBAR1 (0.69) LMNAPTPN1NT5EUSP2HIF1A
SCHEMBL3507541 0.87 GPBAR1 (0.69) LMNAPTPN1NT5EUSP2HIF1A
SCHEMBL16704671 0.86 EGLN2 (0.65) LMNAPTPN1NT5EUSP2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144688-A1 23-Substituted Derivatives of Lupane-type Pentacyclic Triterpenoids ADVANCED LIFE SCIENCES, INC. (US) 2010-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144688-A1 23-Substituted Derivatives of Lupane-type Pentacyclic Triterpenoids BRCA1, PGF, LSS LMNA 1419/4885PTPN1 3524/4885NT5E 4392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback